Хуудас 1 -аас 16 үр дүн
FIELD OF THE INVENTION
The present invention relates to a method for treating neuronal insult, such as caused by lack of oxygen, in neurons prone to Parkinsonian degeneration, by administering to a patient an ATP-sensitive potassium channel blocker.
BACKGROUND OF THE INVENTION
A species of potassium
FIELD OF THE INVENTION
This invention relates to coffee products having an increased content of potassium and to the use of foods and beverages having an increased potassium content to enhance the gastric acid response in persons with low gastric acid secretion, especially individuals having
TECHNICAL FIELD
The present invention belongs to the field of pharmacy. In particular, the present invention relates to a class of novel compounds agonist which can be used as potassium ion channels agonist, the preparation method thereof, and the use of the compounds agonist or the pharmaceutically
BACKGROUND OF THE INVENTION
This invention relates to the treatment of degenerative diseases of the central nervous system, such as those associated with aging and senile dementia of the Alzheimer's type (hereinafter referred to by the abbreviation SDAT). In particular, this invention also relates
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
FIELD OF THE INVENTION
The present invention relates to novel methods for the treatment or prevention of glaucoma, ocular hypertension, and other ophthalmic disorders exhibiting elevated intraocular pressure, as well as ocular disorders characterized by retinal neurodegeneration or edema including
FIELD OF INVENTION
The present invention is directed to compositions of nutritional supplements. Specifically, the invention relates to a unique compound that, when ingested by mammals, is capable of repairing and regenerating articular cartilage, resulting in relief from associated symptoms of
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national stage application of PCT Application No. PCT/JP2012/058391, filed Mar. 29, 2012, which claims the benefit of Japanese Application No. JP 2011-084819, filed Apr. 6, 2011, in the Japanese Patent Office. All disclosures of the
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates in general to aspirin compositions, and in particular to a new and useful water-soluble aspirin composition and the method of making the same.
Aspirin is the most widely used drug in the world. It has a number of important uses in
TECHNICAL FIELD
The present invention relates to an electrode for a non-aqueous electrolyte secondary battery negative electrode containing a carbonaceous material and graphite.
BACKGROUND ART
In recent years, the notion of mounting large lithium-ion secondary batteries, having high energy density
FIELD OF THE INVENTION
The invention relates to pH adjustors for drinks comprising a potassium salt as an active ingredient and to drinks using the pH adjustors.
BACKGROUND OF THE INVENTION
There are many species of coffees having different aromas and tastes (e.g., sweetness, mellowness, bitterness,
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase patent application of International Application Ser. No. PCT/IB2011/002984, filed on Dec. 9, 2011, and which claims the benefits of European Patent Application No. 10015591.0, and of Italian Patent Application No.
FIELD OF THE INVENTION
The present invention relates to a method for treating neuronal insult, such as caused by lack of oxygen, in neurons prone to Parkinsonian degeneration, by administering to a patient an ATP-sensitive potassium channel blocker.
BACKGROUND OF THE INVENTION
A species of potassium